3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Immune Complex Diseases: new trials by email Literature Review of Immune Complex Diseases trials Research Report on Immune Complex Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis bezuclastinib - Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN) | Phase 2 | Recruiting | Cogent Biosciences, Inc. | 140 | 2021-11-09 | 2026-09-15 |
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases Sparsentan - Focal Segmental Glomerulosclerosis, Minimal Change Disease | Phase 2 | Recruiting | Travere Therapeutics, Inc. | 67 | 2021-08-12 | 2026-05-12 |
| A Randomized Multicenter Study for Isolated Skin Vasculitis Colchicine, Dapsone, Azathioprine - Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa | Phase 2 | Recruiting | University of Pennsylvania | 90 | 2017-01-01 | 2026-08-20 |
IgA Vasculitis (2) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hypersensitivity (1) · Immune System Diseases (1) · Leukemia (1) · Leukemia, Mast-Cell (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Macular dystrophy, corneal type 1 (1) · Mastocytosis (1)
Hemic and Lymphatic Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Skin and Connective Tissue Diseases (3) · Blood Coagulation Disorders (2) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Hematologic Diseases (2) · Hemorrhage (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Hypersensitivity (2) · Immune System Diseases (2) · Purpura (2)
Azathioprine (1) · Colchicine (1) · Dapsone (1) · sparsentan (1)
Cogent Biosciences, Inc. (1) · Travere Therapeutics, Inc. (1) · University of Pennsylvania (1)
United States (3) · Canada (2) · Germany (2) · Italy (2) · Netherlands (2) · Poland (2) · Spain (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · France (1) · Japan (1) · Norway (1) · Sweden (1)
Christian Pagnoux, MD, MPH, MSc (1) · Rachael Easton, MD, Ph.D. (1) · Radko Komers, MD, PhD (1) · Robert Micheletti, MD (1)
PMID 32345372, PMID 36853224, PMID 38724717, PMID 40938675, PMID 42384439
U54AR057319 (1)